Tag: Glythera
LegoChem and Iksuda Expand License Agreement
Iksuda Therapeutics and LegoChem Biosciences have confirmed that they have expanded their research collaboration and License Agreement to explore additional ADC programs. The collaboration...
Femtogenix Signs License Agreement with Iksuda Therapeutics
Iksuda Therapeutics, formerly known as Glythera, confirmed that it has signed a licensing agreement with Femtogenix. The agreement gives Iksuda access to Femtogenix’s therapeutic,...
Glythera and IONTAS Collaborate in the Development of Multiple Antibodies for...
Glythera and IONTAS, a biotechnology company offering cutting-edge antibody discovery using its Phage Display Technology, have agreed to collaboration in the development of the...
Glythera Wins Grant to Develops Portfolio of PermaLink®-based ADCs
Glythera, a UK-based company has won a UK £ 1 million (US $ 1,12 million) Innovate UK grant to fund a new project to...
Avacta and Glythera Partner to Develop Novel, Highly Targeted, Drugs
Avacta Life Sciences, the developer of Affimer® biotherapeutics and research reagents will collaborate with Glythera a developer of advanced, stable conjugation chemistries and novel, ultra-potent...
